Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SpainBack to Spain

Clinical trials in El Palmar

3 clinical trials in El Palmar, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
El Palmar at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in El Palmar

Open in trial search

Factor VIII deficiency+1

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Fidanacogene Elaparvovec
  • Sponsor:Pfizer Inc.

Neuroblastoma

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:Institut Gustave Roussy

Study of BI-1206, Rituximab, and Acalabrutinib for Patients with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma

Not recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:BioInvent International AB

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in El Palmar

What the registry says about research in the country

01 El Palmar
Hemic and Lymphatic Diseases
In El Palmar, hemic and lymphatic diseases are being studied through trials focused on indolent B-cell non-Hodgkin lymphoma and hemophilia. The research is centered on improving treatment options, assessing safety, and understanding longer-term outcomes for patients. Evaluating a new antibody-based approach for relapsed or refractory lymphoma Studying combination strategies with established lymphoma therapies Tracking long-term safety and effectiveness in hemophilia A and hemophilia B These studies aim to support better disease control while also helping clinicians understand how durable treatment benefits may be over time.
Neoplasms
Research in neoplasms includes trials for high-risk neuroblastoma, with a strong focus on improving survival and response to treatment. The studies are designed to compare treatment approaches and refine cancer care for children and young people. Comparing different high-dose treatment strategies for neuroblastoma Assessing the value of radiotherapy for residual tumor disease Testing chemoimmunotherapy for patients with an insufficient metastatic response This work reflects an active effort in cancer research to improve outcomes for a difficult-to-treat pediatric malignancy.
B-Cell Lymphoma Research
A key area of study in El Palmar is treatment for relapsed or refractory B-cell non-Hodgkin lymphoma. The trials are exploring whether newer targeted combinations can improve disease control and patient tolerability. Investigating targeted therapy with rituximab Examining added benefit from combining therapies for harder-to-treat lymphoma Focusing on safety and recommended dosing approaches The goal is to expand options for patients whose lymphoma has returned or no longer responds well to standard care.
Hemophilia and Long-Term Gene Therapy Follow-Up
Trials in hemophilia A and severe to moderately severe hemophilia B are looking beyond immediate treatment effects to understand lasting safety and benefit. This includes follow-up on people who previously received advanced gene therapy approaches. Monitoring long-term safety after treatment Assessing durability of factor-related expression Supporting better understanding of treatment persistence in bleeding disorders These studies are important for building confidence in newer therapies for chronic blood-clotting conditions.
Pediatric Oncology in High-Risk Neuroblastoma
The high-risk neuroblastoma program examines how different treatment sequences may improve outcomes for children with aggressive disease. Research efforts are aimed at strengthening both survival rates and disease response after initial therapy. Comparing treatment pathways after induction therapy Reviewing the role of high-dose chemotherapy and radiotherapy Exploring added immune-based treatment for limited response This trial area combines pediatric cancer care with efforts to personalize treatment according to response.
Back to SpainAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.